You are here

diabetes

AstraZeneca enlists SK Chemicals to produce diabetes combo drug Sidapvia

Fierce Pharma

Mon, 07/24/23 - 09:42 pm

drug manufacturing

Researchers Develop Cutting-Edge Assay for Diabetes

Medical Devices and Diagnostics Industry

Wed, 07/19/23 - 05:58 pm

Indian Institute of Science

TheracosBio teams with Mark Cuban's Cost Plus to launch Brenzavvy at bargain price

Fierce Pharma

Sun, 07/16/23 - 02:50 pm

Mark Cuban Cost Plus Drugs

Tandem’s Mobi insulin pump could reaccelerate growth next year: analyst

Medtech Dive

Thu, 07/13/23 - 09:58 am

Tandem Diabetes Care

Mobi insulin pump

Medtronic secures Medicare coverage for MiniMed 780G insulin pump

Medtech Dive

Tue, 07/11/23 - 10:00 am

Ozempic Sales Are Soaring -- Here's Why They Could Go Even Higher

Motley Fool

Thu, 07/6/23 - 11:17 am

Abbott Wins Landmark Reimbursement Decision in France

Medical Devices and Diagnostics Industry

Thu, 06/29/23 - 11:04 pm

Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments

Yahoo/Reuters

Thu, 06/29/23 - 11:56 am

Diabetes Tech: A Catalyst Rich Sector with a Dazzling Future

Medical Devices and Diagnostics Industry

Tue, 06/27/23 - 11:38 am

Medtronic links 780G insulin pump to benefits in kids as it works to grow sales

Medtech Dive

Tue, 06/27/23 - 11:31 am

ADA says all diabetes patients should be screened for nonalcoholic fatty liver disease

Stat

Sun, 06/25/23 - 09:43 pm

Diabetes will be ‘a defining disease of this century’ as global cases are set to surpass one billion by 2050

Stat

Thu, 06/22/23 - 10:49 pm

Novo Nordisk says EMA raised safety signal on drugs including semaglutide

Yahoo/Reuters

Thu, 06/22/23 - 10:21 am

ADA 2023 preview – Lilly’s oral obesity data leave room for Pfizer

EP Vantage

Wed, 06/21/23 - 10:38 am

Eli Lilly's Mounjaro is primed to surpass Novo Nordisk's popular diabetes and obesity duo: report

Fierce Pharma

Mon, 06/19/23 - 10:29 am

This Biotech Is Developing The Next Ozempic

Motley Fool

Fri, 06/16/23 - 10:11 am

Structure Therapeutics

Cost Plus Drugs ends plan to sell insulin

Beckers Hospital Review

Wed, 06/14/23 - 06:34 pm

Mark Cuban Cost Plus Drugs

Lilly, Takeda Face Class-Action Racketeering Lawsuit Over Diabetes Drug

BioSpace

Thu, 06/8/23 - 10:13 am

Novo Nordisk Eyes a Bigger Piece of the Diabetes Market

Medical Devices and Diagnostics Industry

Tue, 06/6/23 - 04:13 pm

Novo Nordisk maintains its defense in case of high-priced insulin – competitor enters settlement

Medwatch

Sun, 06/4/23 - 04:19 pm

Pages